Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System
NCT00879268 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2009-04-09
Summary
This is a pilot trial of centrifugal machine preservation of donor livers for transplantation using a novel preservation solution.
Conditions
- Liver Transplantation
- Organ Preservation
Interventions
- DEVICE
-
Vasosol Organ Perfusion Solution and Medtronic Portable Bypass System
Utilization of Vasosol with Medtronic System for Machine Preservation of the Liver for Liver Transplantation
Sponsors & Collaborators
-
Health Resources and Services Administration (HRSA)
collaborator FED -
Polyak, Maximilian
lead INDIV
Principal Investigators
-
James V. Guarrera, M.D. · Columbia University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-07-31
- Primary Completion
- 2008-02-29
- Completion
- 2009-02-28
More Related Trials
-
Safety and Effectiveness of the Medtronic Resting Heart Bypass System in Heart Surgery Patients
NCT00303641 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Evaluation of a Modular Extracorporeal Circulation Circuit
NCT02000544 ·Status: COMPLETED ·Phase: NA
-
Getinge's Beating Heart Product Family Post-Market Clinical Follow-up (PMCF) Study
NCT07286890 ·Status: RECRUITING
-
Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation
NCT05045794 ·Status: COMPLETED ·Phase: NA
-
Cardiopulmonary Bypass (CPB) Pumps and Blood Activation
NCT00187967 ·Status: UNKNOWN ·Phase: NA
-
RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility Study
NCT00596726 ·Status: COMPLETED ·Phase: PHASE2
-
Best Bypass Surgery (BBS) Trial
NCT00120991 ·Status: UNKNOWN ·Phase: PHASE3
-
Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes
NCT01313533 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass
NCT01435304 ·Status: COMPLETED ·Phase: NA
-
Remote Ischemic Conditioning to Attenuate Myocardial Death and Improve Operative Outcome.
NCT03363958 ·Status: UNKNOWN ·Phase: PHASE2
-
The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients.
NCT01675453 ·Status: COMPLETED ·Phase: PHASE2
-
Hemoperfusion Efferon LPS During Cardiac Surgery Using Cardiopulmonary Bypass
NCT06659289 ·Status: TERMINATED ·Phase: NA
-
OCS Heart Perfusion Post-Approval Registry
NCT05047068 ·Status: ACTIVE_NOT_RECRUITING
-
Integration of Minimal Invasive Cardiopulmonary Bypass System and the Research of Its Blood Compatibility
NCT04476342 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Safety and Effectiveness of The SherpaPak in Donation After Circulatory Death Heart Transplantation
NCT05038943 ·Status: COMPLETED ·Phase: NA
-
Compare Endoscopic and Open Methods of Vein Harvesting for Coronary Artery Bypass Grafting
NCT02446522 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Minimal Versus Conventional Extracorporeal Circulation in Coronary Surgery
NCT01603589 ·Status: COMPLETED ·Phase: NA
-
Hypertonic Solution in Off Pump Coronary Artery Bypass Graft Surgery
NCT01463917 ·Status: UNKNOWN ·Phase: PHASE4
-
Post Static Cold Storage Normothermic Machine Liver Perfusion
NCT03176433 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Cell Savers and Blood Quality
NCT02046824 ·Status: TERMINATED ·Phase: NA
-
Initial Evaluation of Vascudyne Coronary Artery Bypass Conduit
NCT06434935 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
On-pump Beating Coronary Artery Bypass Grafting by Ventricular Assist
NCT02731794 ·Status: UNKNOWN ·Phase: PHASE4
-
Cardiopulmonary Circuits in the Pediatric Population
NCT00208728 ·Status: COMPLETED ·Phase: NA
-
Effects of Cardiopulmonary Bypass (CPB)-Leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function
NCT01469676 ·Status: COMPLETED ·Phase: NA
-
Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass
NCT00978588 ·Status: COMPLETED ·Phase: NA